-$0.66 EPS Expected for Forty Seven Inc (FTSV) This Quarter

Share on StockTwits

Equities analysts expect that Forty Seven Inc (NASDAQ:FTSV) will post earnings of ($0.66) per share for the current quarter, Zacks reports. Zero analysts have made estimates for Forty Seven’s earnings, with estimates ranging from ($0.71) to ($0.60). The firm is expected to announce its next earnings report on Tuesday, February 12th.

According to Zacks, analysts expect that Forty Seven will report full year earnings of ($3.42) per share for the current fiscal year, with EPS estimates ranging from ($4.03) to ($2.38). For the next fiscal year, analysts forecast that the firm will post earnings of ($2.74) per share, with EPS estimates ranging from ($2.93) to ($2.37). Zacks’ EPS calculations are a mean average based on a survey of research analysts that follow Forty Seven.

Forty Seven (NASDAQ:FTSV) last issued its earnings results on Tuesday, November 13th. The company reported ($0.71) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.54) by ($0.17).

A number of equities analysts have recently issued reports on the company. Zacks Investment Research raised Forty Seven from a “sell” rating to a “hold” rating in a research note on Friday, November 9th. HC Wainwright assumed coverage on Forty Seven in a research note on Friday, November 30th. They set a “buy” rating and a $21.00 target price for the company. ValuEngine raised Forty Seven from a “hold” rating to a “buy” rating in a research note on Thursday, November 1st. Finally, Morgan Stanley increased their target price on Forty Seven from $25.00 to $26.00 and gave the stock an “overweight” rating in a research note on Thursday, October 11th. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $25.60.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Citadel Advisors LLC purchased a new position in Forty Seven in the 2nd quarter valued at approximately $3,751,000. Laurion Capital Management LP purchased a new position in Forty Seven in the 2nd quarter valued at approximately $2,000,000. Millennium Management LLC purchased a new position in Forty Seven in the 2nd quarter valued at approximately $1,940,000. BlackRock Inc. purchased a new position in Forty Seven in the 2nd quarter valued at approximately $548,000. Finally, Acuta Capital Partners LLC purchased a new position in Forty Seven in the 2nd quarter valued at approximately $1,168,000. 41.44% of the stock is owned by hedge funds and other institutional investors.

Shares of FTSV stock remained flat at $$18.41 during trading hours on Monday. The stock had a trading volume of 97,379 shares, compared to its average volume of 90,909. Forty Seven has a fifty-two week low of $12.02 and a fifty-two week high of $19.82.

About Forty Seven

Forty Seven Inc, a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized IgG4 subclass monoclonal antibody against CD47 that is in Phase 1b/2 clinical trials used for the treatment of cancer; and FSI-189, an antibody that binds to SIRPa for the treatment of solid tumors.

Recommended Story: How to Calculate Compound Annual Growth Rate (CAGR)

Get a free copy of the Zacks research report on Forty Seven (FTSV)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Forty Seven (NASDAQ:FTSV)

Receive News & Ratings for Forty Seven Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forty Seven and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply